Cargando…
Mast Cell Desensitization in Allergen Immunotherapy
Allergen immunotherapy (AIT) is the only treatment with disease-transforming potential for allergic disorders. The immunological mechanisms associated with AIT can be divided along time in two phases: short-term, involving mast cell (MC) desensitization; and long-term, with a regulatory T cell (Treg...
Autores principales: | López-Sanz, Celia, Jiménez-Saiz, Rodrigo, Esteban, Vanesa, Delgado-Dolset, María Isabel, Perales-Chorda, Carolina, Villaseñor, Alma, Barber, Domingo, Escribese, María M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278139/ https://www.ncbi.nlm.nih.gov/pubmed/35847161 http://dx.doi.org/10.3389/falgy.2022.898494 |
Ejemplares similares
-
The Role of Sphingolipids in Allergic Disorders
por: Díaz-Perales, Araceli, et al.
Publicado: (2021) -
Grand Challenges in Allergen Immunotherapy
por: Cox, Linda
Publicado: (2021) -
Protocol to desensitize human and murine mast cells after polyclonal IgE sensitization
por: López-Sanz, Celia, et al.
Publicado: (2022) -
Lipid Ligands and Allergenic LTPs: Redefining the Paradigm of the Protein-Centered Vision in Allergy
por: Gonzalez-Klein, Zulema, et al.
Publicado: (2022) -
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
por: Jakwerth, Constanze A., et al.
Publicado: (2022)